📝 Dhampur Bio Organics Limited — results explained
Quarter ended June 2026 (Q1 FY27)
Dhampur Bio Organics Limited reported revenue of ₹554 crore for the quarter ended June 2026 (Q1 FY27), down 1.6% from ₹563 crore in the same quarter last year, and up 0.3% sequentially over the March 2026 quarter.
The company reported a net loss of ₹12 crore, against a net loss of ₹19 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-1.84.
Operating profit stood at ₹11 crore — an operating margin (OPM) of 2.0%, compared with 0.9% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Dhampur Bio Organics Limited posted revenue of ₹2,392 crore, a growth of 27.0% over FY25, with a net profit of ₹28 crore (up 131.6% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹2,383 crore with a net profit of ₹35 crore.
Valuation snapshot
At the current price of ₹140.73, DBOL has a market capitalisation of ₹926 crore and a trailing P/E of about 26.3.
Within the Sugar industry, it is the 13th-largest of the 40 companies we track by market value.
Shareholding pattern
As of Mar 2026, promoters held 50.65%, foreign institutional investors (FIIs) 0.54%, domestic institutional investors (DIIs) 0.79%, public shareholders 47.11% of Dhampur Bio Organics Limited.